World
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage
Products of Hims & Hers displayed. Hims & Hers Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drugs Wegovy and diabetes treatment Ozempic. Those […]
Read More
Goldman’s portfolio of hedge fund favorites is trouncing the market this year. Here’s what’s in it
While the S & P 500 is trading close to its all-time high, a group of favored stocks among hedge funds is soaring even higher, according to Goldman Sachs. The S & P 500 reached an all-time intraday high as well as a new closing record on Wednesday, the broad market index’s second consecutive record […]
Read More
Google to be hit with EU charges of breaching Big Tech rules: Reuters
Future Publishing | Future Publishing | Getty Images Alphabet unit Google is set to be charged with breaching EU rules aimed at checking the power of Big Tech after proposed changes to its search results failed to address the EU antitrust regulator’s concerns and those of its rivals, three people with direct knowledge of the matter […]
Read More
Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A shortage of Danish drugmaker Novo Nordisk’s popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, the U.S. Food and Drug Administration’s website showed on […]
Read More
Coinbase says SEC dropping enforcement case as CEO calls for end to ‘bogus’ actions against crypto
Coinbase announced Friday that the Securities and Exchange Commission has agreed to drop its enforcement case against the company, pending the approval of the regulator’s commissioners. Shares of Coinbase rose 4% in premarket trading. In 2023, the SEC charged Coinbase with operating an unregistered securities exchange and for failing to properly register its crypto staking […]
Read More
‘We felt at home’: Israeli weapons firms out in force at Abu Dhabi defense expo
Attendees at IDEX in Abu Dhabi visit the Israel pavilion during the Middle East’s largest defense expo on Feb. 18, 2025 Natasha Turak | CNBC ABU DHABI, United Arab Emirates – A record 34 Israeli companies exhibited at IDEX this week, the Middle East’s largest defense expo hosted biennially by Abu Dhabi. After fifteen months […]
Read More
Trump administration hasn’t complied with order to halt foreign aid freeze, judge says
U.S. President Donald Trump looks on in the Oval Office at the White House in Washington, U.S. Feb. 4, 2025. Elizabeth Frantz | Reuters The Trump administration has not fully complied with a court order pausing the freezing of foreign assistance grants and contracts, a federal judge ruled Thursday. U.S. District Judge Amir Ali last […]
Read More
Google, Meta execs blast Europe over strict AI regulation as Big Tech ups the ante
STOCKHOLM — Executives at U.S. tech giants Google and Meta said that Europe’s artificial intelligence industry is being held back by excessive regulation, adding to rhetoric from Donald Trump’s administration that the region’s strict tech rules are choking innovation. Speaking at the Techarena tech conference in Stockholm, Sweden, public policy chiefs at both Google and […]
Read More
Beijing embraces DeepSeek to lead AI adoption as it looks for new growth drivers
This week’s news that the DeepSeek Chatbot app, developed by China, was downloaded from the Apple app store significantly more times than the US-developed ChatGPT from Open AI, wiped billions off the global tech market. Leon Neal | Getty Images News | Getty Images DeepSeek’s sudden splash in the large language model space has given […]
Read More
Europe stocks set for muted open after Thursday’s sell-off on Wall Street
Standard Chartered beats market expectations Standard Chartered has beaten market forecasts with its latest results, as the bank made $1.6 billion for the fourth quarter before setting aside money for bad loans. The bank did particularly well in its wealth management arm, according to Jefferies analysts, where income rose by more than a third compared […]
Read More